Metabolic regulation signaling pathway detection provides researchers with precise, multi-level analysis of the molecular networks that control cellular energy homeostasis, nutrient sensing, and metabolic flux. Our comprehensive testing platform covers key pathways including AMPK, mTOR, PI3K-AKT/insulin, HIF-1, and PPAR signaling, delivering reliable quantitative data for metabolic disease research, drug development, and functional mechanism studies. With validated antibodies, standardized protocols, and expert data interpretation, we support publications, regulatory submissions, and translational research from a single sample to large-scale cohort studies.
Technical Overview
Metabolic regulation signaling pathways are the molecular circuits that allow cells and organisms to sense nutrient availability, energy status, oxygen supply, and hormonal signals, and to mount appropriate metabolic responses. Dysregulation of these pathways underlies a broad spectrum of human diseases, including type 2 diabetes, obesity, non-alcoholic fatty liver disease (NAFLD), cardiovascular disease, cancer, and age-related degenerative disorders. Accurate detection of pathway activity at the protein, mRNA, and functional levels is therefore essential for elucidating disease mechanisms and evaluating therapeutic interventions.
Our metabolic regulation signaling pathway detection service is built on a mature molecular biology platform integrating protein expression profiling, phosphorylation analysis, transcriptional quantification, and metabolic functional assays. We monitor both total protein and activated (phosphorylated) forms of key signaling nodes, enabling researchers to distinguish between changes in pathway component abundance and changes in pathway activation state. Each project is supported by rigorous internal controls, biological replicate design consultation, and publication-ready data presentation.
The core signaling networks covered by this service include:
- AMPK signaling pathway: the master energy sensor governing catabolic and anabolic balance
- mTORC1/mTORC2 signaling pathway: the central regulator of growth-factor and nutrient-driven biosynthesis
- PI3K-AKT-insulin signaling pathway: the principal axis of glucose uptake and storage
- HIF-1 signaling pathway: the hypoxia-responsive regulator of glycolytic metabolism
- PPAR and SREBP signaling pathways: transcriptional control of lipid and fatty acid metabolism
- Sirtuin-NAD signaling axis: the nutrient-sensitive deacetylase network linking metabolism to aging
Testing Samples
We accept a wide range of biological sample types, with recommended preparation and shipping conditions summarized below. Proper sample handling is critical for preserving labile phosphorylation epitopes and enzymatic activities.
Cultured Cell Samples
Adherent and suspension cell lines, primary cells, and stem cell derivatives are all suitable for pathway analysis. Cells can be shipped as live cultures, snap-frozen cell pellets, or total protein lysates extracted in RIPA buffer with phosphatase and protease inhibitors.
- Minimum input: 1 × 10⁶ cells per detection target for Western blot analysis
- Recommended: pre-treatment conditions (agonists, inhibitors, starvation, hypoxia) should be documented for accurate interpretation
- Frozen pellets should be shipped on dry ice to preserve phosphorylation status
Animal Tissue Samples
Metabolically active tissues from rodent models, including liver, skeletal muscle, epididymal/inguinal adipose tissue, hypothalamus, pancreas, and heart, are routinely analyzed. Tumor xenografts and genetically engineered model tissues are also accepted.
- Recommended mass: 50–100 mg tissue per target panel
- Tissues should be dissected rapidly, rinsed in ice-cold PBS, and flash-frozen in liquid nitrogen within 5 minutes of collection
- For paired phospho/total protein analysis, avoid freeze-thaw cycles; aliquot tissue prior to freezing
Clinical and Biological Fluid Samples
Human serum, plasma, cerebrospinal fluid, and frozen tissue specimens from clinical studies or biobanks can be evaluated for secreted metabolic hormones, cytokines, and pathway biomarkers.
- Serum/plasma volume: 200–500 µL per ELISA panel, shipped on dry ice
- Human specimens must be de-identified and accompanied by appropriate ethical documentation
- Paraffin-embedded (FFPE) sections are accepted for immunohistochemical pathway analysis
Testing Items
Our standard detection panels are organized around six major metabolic regulatory networks. Custom target combinations can be configured on request.
AMPK Energy Sensing Pathway Panel
The AMP-activated protein kinase cascade is examined to evaluate cellular energy stress responses and catabolic activation.
- Total AMPK (α1/α2) and phospho-AMPKα (Thr172)
- Upstream kinases: LKB1, CaMKKβ, and phospho-LKB1 (Ser428)
- Downstream substrates: phospho-ACC (Ser79), phospho-ULK1 (Ser317/Ser555), phospho-Raptor (Ser792)
- Functional readouts: ACC, CPT1A, PGC-1α, and mitochondrial biogenesis markers
mTOR Nutrient Signaling Pathway Panel
The mechanistic target of rapamycin network is quantified to assess nutrient-driven anabolic signaling and protein synthesis.
- Total mTOR, phospho-mTOR (Ser2448), and phospho-mTOR (Ser2481)
- mTORC1 components: Raptor, mLST8, Deptor; mTORC2 components: Rictor, Sin1
- Downstream effectors: phospho-p70S6K (Thr389), phospho-4E-BP1 (Thr37/46, Ser65), phospho-S6 (Ser235/236)
- Feedback nodes: phospho-AKT (Ser473) via mTORC2, and phospho-IRS-1 (Ser307) feedback inhibition
PI3K-AKT-Insulin Signaling Pathway Panel
This panel evaluates insulin sensitivity and glucose homeostasis signaling from receptor to metabolic effector.
- Insulin receptor (INSR), IRS-1/IRS-2, and phospho-IRS-1 (Tyr612)
- PI3K (p85/p110), PDK1, and PTEN expression
- Total AKT and phospho-AKT (Thr308, Ser473)
- Metabolic effectors: phospho-GSK3β (Ser9), GLUT4, glycogen synthase, phospho-FoxO1 (Ser256)
- Secreted markers: insulin, C-peptide, adiponectin, and leptin by ELISA
HIF-1 Hypoxia-Metabolism Pathway Panel
Hypoxic metabolic adaptation is assessed through HIF-1α stabilization and glycolytic gene induction, with relevance to tumor metabolism and ischemic injury.
- HIF-1α and HIF-2α protein accumulation (with hydroxylation-sensitive detection)
- Regulators: PHD2/EGLN1, VHL, and p300/CBP co-activators
- Glycolytic targets: GLUT1, HK2, PFKFB3, LDHA, PDK1
- Angiometabolic outputs: VEGFA and CAIX
PPAR/SREBP Lipid Metabolism Pathway Panel
Transcriptional control of lipid handling is profiled to support fatty liver, dyslipidemia, and adipogenesis studies.
- PPARα, PPARδ, and PPARγ (total and nuclear localization)
- SREBP-1c and SREBP-2 (precursor and cleaved nuclear forms)
- Lipogenesis enzymes: FASN, ACC, SCD1, and DGAT
- β-oxidation and transport: CPT1A, ACOX1, LXRα, ABCA1, and CD36
- Adipocyte markers: C/EBPα, FABP4/aP2, and adiponectin
Sirtuin-NAD Metabolic Regulation Panel
The nicotinamide adenine dinucleotide-dependent deacetylase network is examined for aging, calorie restriction, and exercise metabolism studies.
- SIRT1–SIRT7 expression and nuclear/cytosolic distribution
- NAMPT (visfatin) and NMNAT1/2 for NAD biosynthesis assessment
- Downstream targets: acetylated p53 (Lys382), acetylated FoxO1, acetylated PGC-1α (Lys residues)
- Downstream effectors: UCP1 for thermogenesis and PGC-1α for mitochondrial function
Testing Methods
A multi-methodological strategy is applied to generate orthogonal evidence of pathway activity, ensuring that conclusions do not rest on a single assay modality.
- Western blot: quantitative chemiluminescent or fluorescence-based detection of total and phosphorylated proteins, with densitometric normalization to housekeeping controls
- Real-time quantitative PCR (qRT-PCR): SYBR Green or TaqMan quantification of pathway gene transcripts with multiple reference gene normalization
- ELISA and multiplex immunoassays: high-sensitivity quantification of insulin, adipokines, and phosphorylated signaling proteins in limited biological fluids
- Immunohistochemistry (IHC) and immunofluorescence (IF): tissue and subcellular localization of pathway activation, including phospho-specific staining with H-score quantification
- Lentiviral luciferase reporter assays: pathway-specific transcriptional activity readouts (e.g., HRE, PPRE, FOXO response elements) in cell models
- Co-immunoprecipitation: assessment of protein complex assembly such as mTORC1/Raptor and LKB1/STRAD/MO25 interactions
- Seahorse extracellular flux analysis: functional validation through oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) profiling
All phosphorylation assays include phosphatase inhibitor protection during lysis, positive and negative stimulation controls, and replicate densitometry. Final deliverables include raw image files, quantified bar graphs with statistical analysis, complete experimental procedures, and a written interpretation of pathway activity changes.
Applications
Metabolic regulation signaling pathway detection supports research and development across multiple therapeutic and scientific domains.
- Diabetes and metabolic syndrome: mechanism studies of insulin resistance, evaluation of insulin sensitizers, and biomarker discovery for glycemic control
- Obesity and adipose biology: analysis of thermogenic activation, adipogenesis, and adipokine signaling in diet-induced obesity models
- Cancer metabolism: characterization of the Warburg effect, AMPK/mTOR dependence, and metabolic vulnerabilities in tumor models and patient-derived samples
- Drug mechanism of action: confirmation that metformin analogs, mTOR inhibitors, kinase inhibitors, or natural product extracts engage the intended metabolic targets
- Functional food and nutraceutical research: demonstration of AMPK activation, lipid metabolism modulation, and NAD+ pathway engagement by dietary compounds
- Exercise physiology and aging: quantification of energy sensing adaptation, mitochondrial biogenesis signaling, and sirtuin-mediated longevity pathways
- NAFLD/NASH and hepatology: staging of lipid accumulation signaling from SREBP-driven lipogenesis through inflammatory progression
FAQ
How many biological replicates are recommended for pathway detection?
For animal studies, we recommend a minimum of 5–6 biological replicates per group to support robust statistical comparison of phosphorylation events, which typically show greater biological variability than total protein measurements. For cell-based experiments, at least 3 independent biological replicates are advised. Our project scientists can assist with power analysis based on expected effect sizes.
Can phosphoprotein signals be reliably detected from frozen archived tissues?
Yes, provided that samples were snap-frozen immediately after collection and have not undergone repeated freeze-thaw cycles. Phosphorylation epitopes such as p-AMPK (Thr172) and p-AKT (Ser473) remain stable for extended periods at −80°C. We recommend providing a small pilot sample first so our team can validate signal quality before processing the full cohort.
What is the typical turnaround time?
Standard Western blot and qRT-PCR panels are completed within 10–15 business days after sample receipt. Projects involving cell culture treatments, reporter assays, or Seahorse functional analysis require 3–5 weeks depending on experimental design. Urgent timelines can be accommodated through expedited scheduling arranged in advance.
Do you offer custom pathway combinations beyond the standard panels?
Yes. Any target with a validated commercially available antibody or an established qPCR primer design can be incorporated into a custom panel. For exploratory studies, our scientists will also propose a rational panel design based on your hypothesis, model system, and existing literature.
What deliverables will I receive?
Every project delivers a complete technical report containing raw and annotated Western blot/PCR images, densitometric quantification normalized to loading controls, statistical analysis, graphical summaries suitable for publication, full experimental protocols, and a written scientific interpretation of the observed pathway changes. All raw data files are transferred to the client upon project completion.
Can you help interpret ambiguous or contradictory pathway results?
Certainly. Metabolic signaling frequently involves feedback loops and time-dependent dynamics that can produce seemingly paradoxical results, such as combined AKT and AMPK activation. Our technical team provides consultation on time-course design, inhibitor validation strategies, and orthogonal assay selection to resolve ambiguous findings and strengthen mechanistic conclusions.